Brugada Risk Score Calculator

Clinical calculation support · Verify results before clinical use

Clinical and ECG Marker Checklist

Select the findings present in the patient. The tally is descriptive and is not a validated probability estimate.

0 Markers

Spontaneous Type 1 ECG pattern

Spontaneous type 1 Brugada pattern on ECG. Distinguish spontaneous from drug-induced pattern.

Checklist

History of syncope

Assess whether the episode is likely arrhythmic; syncope has multiple possible causes.

Checklist

Family history of sudden cardiac death

Record relevant family history; its prognostic value for an individual patient is uncertain.

Checklist

Fragmented QRS on ECG

A proposed ECG marker; definitions and prognostic performance vary between studies.

Checklist

Early repolarization in inferolateral leads

An associated ECG marker reported in some Brugada cohorts.

Checklist
0 Selected
Descriptive tally

0 of 5 markers selected

No listed markers are currently selected. This is not a low-risk classification.

Important: This tally does not calculate an individual risk of ventricular arrhythmia or sudden cardiac death and must not be used alone to decide on an ICD or other treatment.

Clinical context

Risk assessment in Brugada syndrome requires clinical interpretation of symptoms, ECG phenotype, and the patient's history. A spontaneous type 1 ECG pattern and probable arrhythmic syncope are important risk markers, but no simple sum of the five findings shown here should be interpreted as a validated risk score.

How to use this checklist

  • Use it to document selected clinical and ECG features, not to assign a risk category.
  • Characterize syncope carefully and assess for documented ventricular arrhythmia or prior cardiac arrest.
  • Interpret findings in the context of specialist assessment and current guideline recommendations.

Evidence and references

Honarbakhsh S, Providencia R, Garcia-Hernandez J, et al. A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK). JACC: Clinical Electrophysiology. 2021;7(2). doi: 10.1016/j.jacep.2020.08.032.
Brugada syndrome: Risk stratification and management. Review discussing the evidence and limitations of clinical and ECG risk markers. Full text.
Morita H, et al. Fragmented QRS as a marker of conduction abnormality and a predictor of prognosis of Brugada syndrome. Circulation. 2008;118:1697–1704. PubMed.
Clinical disclaimer: This educational checklist is not a diagnostic instrument, validated prognostic score, or substitute for clinical judgement. It does not estimate absolute event risk or recommend treatment. Decisions about risk stratification and ICD therapy require assessment by a qualified clinician using the full clinical picture and applicable guidelines.